| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562278 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562414 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562434 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562449 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562454 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562476 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562643 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562644 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562646 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562689 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562702 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562785 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562786 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562803 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562787 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR562849 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR563011 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR563026 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Breast-Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR565913 | n/a | ORIGENE TECHNOLOGIES |
| Human RNA: Breast-Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR566333 | n/a | ORIGENE TECHNOLOGIES |
| Human RNA: Breast-Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR566334 | n/a | ORIGENE TECHNOLOGIES |
| Human RNA: Breast-Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR566341 | n/a | ORIGENE TECHNOLOGIES |
| Human RNA: Breast-Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR566342 | n/a | ORIGENE TECHNOLOGIES |
| Human RNA: Breast-Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR566346 | n/a | ORIGENE TECHNOLOGIES |
| Human RNA: Breast-Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIES | CR565914 | n/a | ORIGENE TECHNOLOGIES |
| Human zyxin (ZYX), transcript variant 2 from ORIGENE TECHNOLOGIES | TP300960 | 20 ug | ORIGENE TECHNOLOGIES |
| HUNK - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN416803 | 1 kit | ORIGENE TECHNOLOGIES |
| Hunk - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN508043 | 1 kit | ORIGENE TECHNOLOGIES |
| Huntingtin-associated protein 1 (HAP1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY406069 | 100 ug | ORIGENE TECHNOLOGIES |
| Huntingtin-associated protein 1 (HAP1), transcript variant 4 from ORIGENE TECHNOLOGIES | LY421569 | 100 ug | ORIGENE TECHNOLOGIES |
| Huntingtin (HTT) from ORIGENE TECHNOLOGIES | LY419529 | 100 ug | ORIGENE TECHNOLOGIES |
| Huntingtin interacting protein 1 (HIP1) from ORIGENE TECHNOLOGIES | LY417370 | 100 ug | ORIGENE TECHNOLOGIES |
| SLC35C1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN400101 | 1 kit | ORIGENE TECHNOLOGIES |
| SLC35C2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN404316 | 1 kit | ORIGENE TECHNOLOGIES |
| SLC9C2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407298 | 1 kit | ORIGENE TECHNOLOGIES |
| SLC9C1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418840 | 1 kit | ORIGENE TECHNOLOGIES |
| Slc35c1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516063 | 1 kit | ORIGENE TECHNOLOGIES |
| Slc35c2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516064 | 1 kit | ORIGENE TECHNOLOGIES |
| Slc9c1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516219 | 1 kit | ORIGENE TECHNOLOGIES |
| Toxoplasma gondii IgG ELISA Kit from ORIGENE TECHNOLOGIES | EA101088 | 96-well strip plate | ORIGENE TECHNOLOGIES |
| Toxoplasma gondii IgM ELISA Kit from ORIGENE TECHNOLOGIES | EA101089 | 96-well strip plate | ORIGENE TECHNOLOGIES |
| GDP dissociation inhibitor 1 (GDI1) from ORIGENE TECHNOLOGIES | LY419896 | 100 ug | ORIGENE TECHNOLOGIES |
| GDP dissociation inhibitor 2 (GDI2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400572 | 100 ug | ORIGENE TECHNOLOGIES |
| GDP dissociation inhibitor 2 (GDI2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426526 | 100 ug | ORIGENE TECHNOLOGIES |
| GDPD3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN401306 | 1 kit | ORIGENE TECHNOLOGIES |
| GDPD2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN404415 | 1 kit | ORIGENE TECHNOLOGIES |
| GDPD5 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN405874 | 1 kit | ORIGENE TECHNOLOGIES |
| GDPD4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN411829 | 1 kit | ORIGENE TECHNOLOGIES |
| GDPD1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN423431 | 1 kit | ORIGENE TECHNOLOGIES |
| Gdpd1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN506396 | 1 kit | ORIGENE TECHNOLOGIES |